semaglutide vs tirzepatide for insulin resistance Let's talk versus Tirzepatide! Semaglutide is a GLP-1 (glucagon-like peptide-medication) and is both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), two key incretin hormones in metabolic regulation. Understanding Overcoming Insulin Resistance in Type

Sounds enticing, right

An additional study called ATTAIN-MAINTAIN found that orforglipron helped people hold onto weight they had previously lost with injectable GLP-1 therapies, opening up a potential step-down strategy for people who want to transition from weekly injections to a simpler daily pill once they have reached their target weight

A 2-month course (60 capsules at 1/day) is generally recommended to see significant results

Phase 3 trials are expected to complete data collection around 2025 to 2026

CLINICAL TRIAL INVESTIGATOR NEW YORK, UNITED STATES "These results really reinforce the role of aesthetic treatments, like Sculptra and Restylane, in supporting patients through their weight loss transformations, showing they can deliver visible improvements in skin quality while also significantly enhancing patient satisfaction and emotional wellbeing